Develop Novel Therapeutics
13/12/2022 15:10
Dec 13 (Reuters) - SK Chemicals Co Ltd 285130.KS :
* CYCLICA AND SK CHEMICALS ANNOUNCE CO-DEVELOPMENT AGREEMENT
TO
CO-DEVELOP NOVEL THERAPEUTICS
Source text for Eikon: ID:nPn175TQ7a
Further company coverage: 285130.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK Chemicals
See all newsBrief: Sk Chemicals Co Aims 11% Operating Margin By 2030
Brief: Sk Chemicals Co Q1 Consolidated Operating. Loss 18.9 Billion Won Versus 24.3 Billion Won Profit A Year Ago
Brief: Sk Chemicals Sells 220 Billion Won Exchangeable Bonds
Brief: SK Chemicals Partners with Durmont to Supply Sustainable Materials to Global Auto Brands
South Korea's mountain of plastic waste shows limits of recycling (updated)